Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Bellicum Pharmaceuticals, Inc. patents

List of Bellicum Pharmaceuticals, Inc. patents

List of Green Mountain Semiconductor, Inc. patents

List of Gilat Satellite Networks patents

List of Optware patents

Investors in Memebox

Investors in Le Tote

Patents where

Current Assignee

Name

is

Bellicum Pharmaceuticals, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9913882 Methods for inducing partial apoptosis using caspase polypeptides	Patent 9913882 was granted and assigned to Bellicum Pharmaceuticals, Inc. on March, 2018 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	9913882	March 13, 2018
	‌ US Patent 10525110 Methods for inducing partial apoptosis using caspase polypeptides	Patent 10525110 was granted and assigned to Bellicum Pharmaceuticals, Inc. on January, 2020 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	10525110	January 7, 2020
	‌ US Patent 9434935 Modified caspase polypeptides and uses thereof	Patent 9434935 was granted and assigned to Bellicum Pharmaceuticals, Inc. on September, 2016 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	9434935	September 6, 2016
	‌ US Patent 8486693 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods	Patent 8486693 was granted and assigned to Bellicum Pharmaceuticals, Inc. on July, 2013 by the United States Patent and Trademark Office.		Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	8486693	July 16, 2013
	‌ US Patent 10934346 Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12	Patent 10934346 was granted and assigned to Bellicum Pharmaceuticals, Inc. on March, 2021 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	10934346	March 2, 2021
	‌ US Patent 9944690 Methods for controlling T cell proliferation	Patent 9944690 was granted and assigned to Bellicum Pharmaceuticals, Inc. on April, 2018 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	9944690	April 17, 2018
	‌ US Patent 10888608 Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides	Patent 10888608 was granted and assigned to Bellicum Pharmaceuticals, Inc. on January, 2021 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	10888608	January 12, 2021
	‌ US Patent 9932572 Modified Caspase polypeptides and uses thereof	Patent 9932572 was granted and assigned to Bellicum Pharmaceuticals, Inc. on April, 2018 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	9932572	April 3, 2018
	‌ US Patent 11839647 Methods for inducing partial apoptosis using caspase polypeptides	Patent 11839647 was granted and assigned to Bellicum Pharmaceuticals, Inc. on December, 2023 by the United States Patent and Trademark Office.	Bellicum Pharmaceuticals, Inc.	Bellicum Pharmaceuticals, Inc.		United States Patent and Trademark Office	11839647	December 12, 2023

9 results

0 selected

9 results

0 selected